![](/img/cover-not-exists.png)
A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancer
Emmanuel S. Antonarakis, Elisabeth I. Heath…Volume:
71
Language:
english
DOI:
10.1007/s00280-013-2079-z
Date:
April, 2013
File:
PDF, 545 KB
english, 2013